CH554874A - Verfahren zur herstellung von gegen die marek'sche krankheit nuetzliche sulfanilylphenylharnstoff-komplexverbindungen. - Google Patents

Verfahren zur herstellung von gegen die marek'sche krankheit nuetzliche sulfanilylphenylharnstoff-komplexverbindungen.

Info

Publication number
CH554874A
CH554874A CH588171A CH588171A CH554874A CH 554874 A CH554874 A CH 554874A CH 588171 A CH588171 A CH 588171A CH 588171 A CH588171 A CH 588171A CH 554874 A CH554874 A CH 554874A
Authority
CH
Switzerland
Prior art keywords
sulphanilylphenylura
disease
preparation
useful against
complexes useful
Prior art date
Application number
CH588171A
Other languages
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of CH554874A publication Critical patent/CH554874A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH588171A 1970-04-22 1971-04-22 Verfahren zur herstellung von gegen die marek'sche krankheit nuetzliche sulfanilylphenylharnstoff-komplexverbindungen. CH554874A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3102570A 1970-04-22 1970-04-22

Publications (1)

Publication Number Publication Date
CH554874A true CH554874A (de) 1974-10-15

Family

ID=21857254

Family Applications (1)

Application Number Title Priority Date Filing Date
CH588171A CH554874A (de) 1970-04-22 1971-04-22 Verfahren zur herstellung von gegen die marek'sche krankheit nuetzliche sulfanilylphenylharnstoff-komplexverbindungen.

Country Status (9)

Country Link
US (1) US3717623A (de)
BE (1) BE766072A (de)
CA (1) CA951726A (de)
CH (1) CH554874A (de)
DE (1) DE2119451A1 (de)
FR (1) FR2092072B1 (de)
GB (1) GB1311618A (de)
NL (1) NL7104785A (de)
ZA (1) ZA712566B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3960955A (en) * 1974-11-15 1976-06-01 Texaco Inc. Purification process
US3998853A (en) * 1975-12-04 1976-12-21 Phillips Petroleum Company 13-Oxatetracyclo[8.2.12,9.0.03,8 ]tridec-5-ene-1,5,6,10-tetracarbonitrile
US4338334A (en) * 1977-12-29 1982-07-06 Merck & Co., Inc. 1-[4-(4-Sulfanilyl)phenyl] urea and derivatives in compositions and methods of treating rheumatoid arthritis and immune complex diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2328548A (en) * 1939-05-27 1943-09-07 Schering Corp Therapeutically valuable derivative of sulfones
GB987252A (en) * 1960-08-29 1965-03-24 Monsanto Canada Ltd Bacteriostatic adducts of pyridine and pyrimidine derivatives

Also Published As

Publication number Publication date
FR2092072A1 (de) 1972-01-21
DE2119451A1 (de) 1971-11-11
FR2092072B1 (de) 1974-05-24
GB1311618A (en) 1973-03-28
NL7104785A (de) 1971-10-26
BE766072A (fr) 1971-10-21
US3717623A (en) 1973-02-20
ZA712566B (en) 1972-12-27
CA951726A (en) 1974-07-23

Similar Documents

Publication Publication Date Title
CH553780A (de) Verfahren zur herstellung von neuen 1,4-dihydropyridinderivaten.
AT315856B (de) Verfahren zur herstellung von neuen 4-hydroxy-6-aryl-bzw.6-heteroarylpyrimidinen
CH551979A (de) Verfahren zur herstellung von 1,2-dihydropyrimidinen.
AT319948B (de) Verfahren zur Herstellung von neuen 2,4-Diamino-5-benzylpyrimidinen
AT317421B (de) Verfahren zur Herstellung von Lebendvirus-Impfstoff gegen die Marek&#39;sche Krankheit
AT312606B (de) Verfahren zur Herstellung von neuen 2,2-Diaryl-4-piperidinbutyramiden
AT310953B (de) Verfahren zur Herstellung von neuen 8,9-Didehydro-10-alkoxyergolenderivaten
AT299968B (de) Verfahren zur Herstellung von neuen 5-Imino-1,2,4-triazin-Derivaten
CH554874A (de) Verfahren zur herstellung von gegen die marek&#39;sche krankheit nuetzliche sulfanilylphenylharnstoff-komplexverbindungen.
AT310140B (de) Verfahren zur Herstellung von 2-Alkyl-2-(3&#39;-oxoalkyl)-cycloalkan-1,3-dionen
CH556352A (de) Verfahren zur herstellung von 2-acylamino-1,3,4-thiadiazol-(thi)onen-(5).
AT320846B (de) Verfahren zur Herstellung des neuen 3&#39;,4&#39;-Dideoxykanamycins B
CH555332A (de) Verfahren zur herstellung von neuen 1,3,3-trisubstituierten 3-azolylpropinen.
CH546730A (de) Verfahren zur herstellung von n,n&#39;-bis-trifluormethyl-tetrafluoraethylendiamin.
AT315142B (de) Verfahren zur Herstellung von neuen 2-(3&#39;-Oxoalkyl)-cycloalkan-1,3-dionen
AT300792B (de) Verfahren zur Herstellung von neuen modifizierten N,N&#39;substituierten 2,4,5-Triketoimidazolidinen
CH557825A (de) Verfahren zur herstellung von 2,3-dihydrobenzodiazepinen.
AT304771B (de) Verfahren zur Herstellung von neuen Pyranosiden von 3β-Hydroxy-4-chlor-carda-4,20(22)-dienoliden
AT306252B (de) Verfahren zur Herstellung von neuen 2,3-Alkylidenrhamnopyranosiden
AT299946B (de) Verfahren zur Herstellung von neuen 1,3-Benzodioxol-2-thionen
CH555330A (de) Verfahren zur herstellung pharmazeutisch wertvoller 1,4benzodioxane.
CH552621A (de) Verfahren zur herstellung von 4-(5&#39;-nitrofurfurylidenamino)-octahydro-4h-1,4-benzthiazin-1,1-dioxid.
AT302504B (de) Verfahren zur Herstellung von neuen 1:1- bzw. 1:2-Schwermetallkomplexen
AT309708B (de) Verfahren zur Herstellung des neuen 1,2α-Methylen-6,7α-difluormethylen-20-spirox-4-en-3-on
AT308749B (de) Verfahren zur Herstellung von 3,5-Dialkylpyridinen

Legal Events

Date Code Title Description
PL Patent ceased